TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE

PROBLEM TO BE SOLVED: To provide a treatment approach which inhibits the fatal effects of sepsis and simultaneously minimizes potentially serious side effects. SOLUTION: There is provided the method for prophylactically or therapeutically treating sepsis or septic shock. The method involves administ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: CREASEY ALBA A
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CREASEY ALBA A
description PROBLEM TO BE SOLVED: To provide a treatment approach which inhibits the fatal effects of sepsis and simultaneously minimizes potentially serious side effects. SOLUTION: There is provided the method for prophylactically or therapeutically treating sepsis or septic shock. The method involves administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from sepsis or other inflammatory conditions. The method also involves the use of continuous intravenous infusion of TFPI or a TFPI analog at low doses to avoid adverse side effects. COPYRIGHT: (C)2010,JPO&INPIT
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2010006839A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2010006839A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2010006839A3</originalsourceid><addsrcrecordid>eNqNirEKwjAQQLs4iPoPh5MOQrRQdLy2CT2xScidlOJQisRJtFD_Hyn4AU4P3nvz5CZBo9TaCjgDrD0TQ94CljVZYgko5OzUhJivGgwW4gJ4lKrBFshWlNNkNmI8bQEFLq6B0rFeJrNH_xzj6sdFsjZaimoXh3cXx6G_x1f8dGd_UHulVHZMT5j-NX0B51YyXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE</title><source>esp@cenet</source><creator>CREASEY ALBA A</creator><creatorcontrib>CREASEY ALBA A</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a treatment approach which inhibits the fatal effects of sepsis and simultaneously minimizes potentially serious side effects. SOLUTION: There is provided the method for prophylactically or therapeutically treating sepsis or septic shock. The method involves administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from sepsis or other inflammatory conditions. The method also involves the use of continuous intravenous infusion of TFPI or a TFPI analog at low doses to avoid adverse side effects. COPYRIGHT: (C)2010,JPO&amp;INPIT</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100114&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010006839A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100114&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010006839A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CREASEY ALBA A</creatorcontrib><title>TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE</title><description>PROBLEM TO BE SOLVED: To provide a treatment approach which inhibits the fatal effects of sepsis and simultaneously minimizes potentially serious side effects. SOLUTION: There is provided the method for prophylactically or therapeutically treating sepsis or septic shock. The method involves administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from sepsis or other inflammatory conditions. The method also involves the use of continuous intravenous infusion of TFPI or a TFPI analog at low doses to avoid adverse side effects. COPYRIGHT: (C)2010,JPO&amp;INPIT</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAQQLs4iPoPh5MOQrRQdLy2CT2xScidlOJQisRJtFD_Hyn4AU4P3nvz5CZBo9TaCjgDrD0TQ94CljVZYgko5OzUhJivGgwW4gJ4lKrBFshWlNNkNmI8bQEFLq6B0rFeJrNH_xzj6sdFsjZaimoXh3cXx6G_x1f8dGd_UHulVHZMT5j-NX0B51YyXg</recordid><startdate>20100114</startdate><enddate>20100114</enddate><creator>CREASEY ALBA A</creator><scope>EVB</scope></search><sort><creationdate>20100114</creationdate><title>TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE</title><author>CREASEY ALBA A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2010006839A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CREASEY ALBA A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CREASEY ALBA A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE</title><date>2010-01-14</date><risdate>2010</risdate><abstract>PROBLEM TO BE SOLVED: To provide a treatment approach which inhibits the fatal effects of sepsis and simultaneously minimizes potentially serious side effects. SOLUTION: There is provided the method for prophylactically or therapeutically treating sepsis or septic shock. The method involves administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from sepsis or other inflammatory conditions. The method also involves the use of continuous intravenous infusion of TFPI or a TFPI analog at low doses to avoid adverse side effects. COPYRIGHT: (C)2010,JPO&amp;INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2010006839A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TREATMENT OF SEPSIS BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AT LOW DOSE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T00%3A00%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CREASEY%20ALBA%20A&rft.date=2010-01-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2010006839A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true